Thesis Comparison of Clinical and Pathophysiological Characteristics of ME/CFS and Chronic Fatigue Associated with Post-COVID-19 Syndrome, 2024, RIABKOVA

Discussion in 'ME/CFS research' started by Dolphin, Jan 2, 2025 at 1:51 PM.

Tags:
  1. Dolphin

    Dolphin Senior Member (Voting Rights)

    Messages:
    6,012
    https://disser.spbu.ru/files/2024/disser_en_riabkova_varvara.pdf

    SAINT PETERSBURG STATE UNIVERSITY
    As a manuscript
    RIABKOVA Varvara Aleksandrovna

    COMPARISON OF CLINICAL AND PATHOPHYSIOLOGICAL CHARACTERISTICS OF MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME AND CHRONIC FATIGUE ASSOCIATED WITH POST-COVID-19 SYNDROME

    Scientific specialities
    3.3.3. Pathological physiology
    3.1.18. Internal medicine

    DISSERTATION for an academic degree candidate of medical sciences.

    Translation from Russian

    Scientific supervisors:
    Churilov Leonid Pavlovich candidate of medical sciences, associate professor
    Shoenfeld Yehuda (Israel) Doctor of Medicine, member of The Israeli Academy of Sciences and Humanities, professor Saint-Petersburg – 2024
     
    Last edited: Jan 2, 2025 at 5:26 PM
  2. Yann04

    Yann04 Senior Member (Voting Rights)

    Messages:
    1,180
    Location:
    Switzerland (Romandie)
    Table of Contents:

     

    Attached Files:

  3. Hutan

    Hutan Moderator Staff Member

    Messages:
    30,105
    Location:
    Aotearoa New Zealand
    Research objectives

    1. To study the prevalence of ME/CFS according to its diagnostic criteria among patients with chronic fatigue associated with PCS.

    2. To determine the signs of dysautonomia based on the analysis of heart rate variability (HRV), blood pressure variability (BPV), and baroreflex function during spontaneous breathing and paced breathing in patients with chronic fatigue associated with PCS and in patients with ME/CFS not related to COVID-19.

    3. To evaluate hypothalamic-pituitary-adrenal (HPA) axis activity with the measurement of the cortisol awakening response (CAR) in patients with chronic fatigue associated with PCS and in patients with ME/CFS not related to COVID-19.

    4. To investigate microvascular endothelial function based on the analysis of post- occlusive reactive hyperemia (PORH) measured by Laser-Doppler flowmetry (LDF) in patients with chronic fatigue associated with PCS and in patients with ME/CFS not related to COVID-19.

    5. To characterize the state of regulatory function of the immune system according to the data on the spectrum and intensity of autoreactive processes reflecting its interaction with cells of different organs and tissues in patients with chronic fatigue associated with PCS and in patients with ME/CFS not related to COVID-19.

    6. To assess microbiome composition according to the data obtained by gas chromatography-mass spectrometry of microbial markers in venous blood of patients with chronic fatigue associated with PCS and in patients with ME/CFS not related to COVID-19.

    7. On the basis of the study results, to assess the degree of similarity and the presence of differences in the pathogenesis of ME/CFS and chronic fatigue associated with PCS.

     
  4. Hutan

    Hutan Moderator Staff Member

    Messages:
    30,105
    Location:
    Aotearoa New Zealand
    The findings from these studies have certainly been widely shared and may well have been influential for the care of people with ME/CFS in Russia
    I really hope the studies were done well.
     
  5. Hutan

    Hutan Moderator Staff Member

    Messages:
    30,105
    Location:
    Aotearoa New Zealand
    "The main provisions for defence

    1. The prevalence of ME/CFS, according to its diagnostic criteria, among patients with chronic fatigue associated with PCS is 45.7%, necessitating increased awareness among physicians about ME/CFS, modern approaches to its diagnosis and therapy.

    2. Patients with ME/CFS not related to COVID-19 and with the chronic fatigue associated with PCS exhibit a similar pattern of dysautonomia, characterized by reduced HRV, increased BPV, and decreased baroreflex sensitivity, and the severity of these signs correlates with the fatigue level.

    3. Microcirculation disorders are characteristic of both groups of patients, but in ME/CFS not related to COVID-19 there is impairment in endothelium-dependent vasodilation, while patients with chronic fatigue associated with PCS shows a decrease in the minimum perfusion value during occlusion, which may indicate microcirculatory stasis.

    4. Decreased reactivity of the HPA axis is typical for the group of patients with ME/CFS not related to COVID-19, in which it is closely linked to sleep disturbances. At the same time HPA reactivity does not appear to be a significant factor in the pathogenesis of chronic fatigue associated with PCS.

    5. Both groups of patients exhibit signs of polyclonal activation of the adaptive immune system, and the analysis of natural autoantibody (AAb) serum profiles, according to the concept of the regulatory function of the immune system, suggests new pathomechanisms of ME/CFS and PCS.

    6. The analysis of the microbiome composition in patients with chronic fatigue associated with PCS and in patients with ME/CFS not related to COVID-19 suggests alterations in the small intestinal microbiota composition, increased mucosal permeability, and immune system dysfunction at the mucosal level, more pronounced in ME/CFS.

    7. Thus, the comparison of findings characterizing the regulatory functions of the nervous, endocrine, and immune systems as well as microcirculation disorders in chronic fatigue associated with PCS, in patients with ME/CFS not related to COVID-19, and in healthy individuals revealed significant similarities in the pathomechanisms of PCS and ME/CFS, as well as some features more typical for each of these syndromes."
     
    ukxmrv, RedFox, pooriepoor91 and 5 others like this.

Share This Page